Literature DB >> 18427553

Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line.

Manisha Bajpai1, Jianying Liu, Xin Geng, Rhonda F Souza, Peter S Amenta, Kiron M Das.   

Abstract

Barrett's epithelium is a precancerous, specialized columnar metaplasia in the distal esophagus. We demonstrate the changes in cellular phenotype in a non-neoplastic Barrett's cell line (BAR-T), following exposure to acid and bile salt, the two important components of gastroesophageal refluxate. Cell phenotypes in BAR-T cell line were quantified by fluorescence-activated cell sorting (FACS) using monoclonal antibodies against markers: cytokeratin 8/18 (CK8/18) for columnar, CK4 for squamous, mAbDas-1 for colonic epithelial cell phenotype and p75NTR for esophageal progenitors. Cells were exposed for 5 min each day to 200 microM glycochenodeoxycholic acid at pH 4, pH 6 and pH 7.4 or only to acid (pH 4) for up to 6 weeks. The BAR-T cell line comprised 35+/-5.2% CK8/18, 32+/-3.5% mAbDas-1, 9.5+/-3% CK4 and 4+/-2.5% p75NTR-positive cells. Single exposure to acid and or bile did not change cell phenotypes. However, chronic treatment for at least 2 weeks significantly enhanced (P<0.05) the expression of colonic phenotype and CK8/18-positive cells, as evidenced by FACS analysis. Bile salt at pH 4 and bile salt followed by acid (pH 4) in succession were the strongest stimulators (P<0.01) for induction of colonic phenotype cells. Squamous (CK4(+)) phenotype did not change by the treatments. Cox-2 expression was induced after acute treatment and increased to twofold during chronic treatment, particularly in response to acidic pH. We conclude that BAR-T cells can be utilized as an 'in vitro' model to study the effect of environmental factors and their influence on the cellular phenotype and molecular changes in the pathogenesis of esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427553     DOI: 10.1038/labinvest.2008.34

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Development and characterization of an organotypic model of Barrett's esophagus.

Authors:  Rachelle E Kosoff; Kristin L Gardiner; Lauren M F Merlo; Kirill Pavlov; Anil K Rustgi; Carlo C Maley
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

2.  Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.

Authors:  Qiuyang Zhang; Agoston T Agoston; Thai H Pham; Wei Zhang; Xi Zhang; Xiaofang Huo; Sui Peng; Manisha Bajpai; Kiron Das; Robert D Odze; Stuart J Spechler; Rhonda F Souza
Journal:  Gastroenterology       Date:  2018-09-27       Impact factor: 22.682

3.  Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Authors:  Aaron Goldman; Hwu Dau Rw Chen; Heather B Roesly; Kimberly A Hill; Margaret E Tome; Bohuslav Dvorak; Harris Bernstein; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-02       Impact factor: 4.052

4.  Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.

Authors:  Kiron M Das; Yingxin Kong; Manisha Bajpai; Diptee Kulkarni; Xin Geng; Pravin Mishra; Debabrata Banerjee; Kim Hirshfield
Journal:  Int J Cancer       Date:  2010-03-22       Impact factor: 7.396

5.  Bile in the esophagus-model for a bile acid biosensor.

Authors:  Dhiren Nehra
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

6.  Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A Delellis; David Lambeth; Weibiao Cao
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

7.  Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A DeLellis; David Lambeth; Rhonda F Souza; Stuart J Spechler; Weibiao Cao
Journal:  Gut       Date:  2009-11-18       Impact factor: 23.059

8.  Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.

Authors:  David H Wang; Anjana Tiwari; Monica E Kim; Nicholas J Clemons; Nanda L Regmi; William A Hodges; David M Berman; Elizabeth A Montgomery; D Neil Watkins; Xi Zhang; Qiuyang Zhang; Chunfa Jie; Stuart J Spechler; Rhonda F Souza
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

9.  mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).

Authors:  Koushik K Das; Hong Xiao; Xin Geng; Carlos Fernandez-Del-Castillo; Vicente Morales-Oyarvide; Ebubekir Daglilar; David G Forcione; Brenna C Bounds; William R Brugge; Martha B Pitman; Mari Mino-Kenudson; Kiron M Das
Journal:  Gut       Date:  2013-11-25       Impact factor: 23.059

10.  HOXA13 in etiology and oncogenic potential of Barrett's esophagus.

Authors:  Vincent T Janmaat; Kateryna Nesteruk; Manon C W Spaander; Auke P Verhaar; Bingting Yu; Rodrigo A Silva; Wayne A Phillips; Marcin Magierowski; Anouk van de Winkel; H Scott Stadler; Tatiana Sandoval-Guzmán; Luc J W van der Laan; Ernst J Kuipers; Ron Smits; Marco J Bruno; Gwenny M Fuhler; Nicholas J Clemons; Maikel P Peppelenbosch
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.